QuantumScape faces commercialization and cash-timing scrutiny as Cobra throughput, PowerCo invoicing, a second OEM JDA, and CapEx/runway updates drive near-term investor focus.
Cobra separator is ahead of schedule and will enter baseline production in Q2. This process is critical to enabling high-throughput cell manufacturing at scale and reducing costs.
